
Kodiak Sciences (NASDAQ:KOD) Posts Earnings Results, Beats Estimates By $0.06 EPS

I'm PortAI, I can summarize articles.
Kodiak Sciences (NASDAQ:KOD) reported quarterly earnings of ($0.84) per share, surpassing analysts' expectations of ($0.87) by $0.03. The stock opened at $3.06, with a market cap of $161.03 million. Jefferies Financial Group upgraded Kodiak Sciences from "hold" to "buy" with a target price of $20.00. The company focuses on developing therapeutics for retinal diseases, with its lead product candidate in advanced clinical studies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

